202 related articles for article (PubMed ID: 8285933)
21. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.
Yeramian E; Garbarg M; Schwartz JC
Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000
[TBL] [Abstract][Full Text] [Related]
22. Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.
Schlicker E; Kathmann M; Reidemeister S; Stark H; Schunack W
Br J Pharmacol; 1994 Aug; 112(4):1043-8. PubMed ID: 7952862
[TBL] [Abstract][Full Text] [Related]
23. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
[TBL] [Abstract][Full Text] [Related]
24. Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?
Schlicker E; Kathmann M; Bitschnau H; Marr I; Reidemeister S; Stark H; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):482-8. PubMed ID: 8740140
[TBL] [Abstract][Full Text] [Related]
25. [Selective stimulation of histamine H3 autoreceptors].
Arrang JM; Garbarg M; Schwartz JC
C R Acad Sci III; 1987; 304(1):11-4. PubMed ID: 3026590
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
[TBL] [Abstract][Full Text] [Related]
27. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
[TBL] [Abstract][Full Text] [Related]
28. A metactoid sensitization model to describe multiple receptors linked to a common response: application to histamine receptors coupled to [3H]cyclic AMP accumulation in guinea pig cortex.
Gannon MN; Hough LB; Weinstein H
Mol Pharmacol; 1989 Feb; 35(2):205-13. PubMed ID: 2537458
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin.
Clark EA; Hill SJ
Eur J Pharmacol; 1996 Jan; 296(2):223-5. PubMed ID: 8838460
[TBL] [Abstract][Full Text] [Related]
30. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
[TBL] [Abstract][Full Text] [Related]
31. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.
Ligneau X; Garbarg M; Vizuete ML; Diaz J; Purand K; Stark H; Schunack W; Schwartz JC
J Pharmacol Exp Ther; 1994 Oct; 271(1):452-9. PubMed ID: 7965746
[TBL] [Abstract][Full Text] [Related]
32. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
Garduño-Torres B; Arias-Montaño JA
Synapse; 2006 Aug; 60(2):165-71. PubMed ID: 16715497
[TBL] [Abstract][Full Text] [Related]
33. High affinity histamine binding site is the H3 receptor: characterization and autoradiographic localization in rat brain.
Cumming P; Shaw C; Vincent SR
Synapse; 1991 Jun; 8(2):144-51. PubMed ID: 1652795
[TBL] [Abstract][Full Text] [Related]
34. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
[TBL] [Abstract][Full Text] [Related]
35. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes.
Harper EA; Shankley NP; Black JW
Br J Pharmacol; 1999 Oct; 128(4):881-90. PubMed ID: 10556922
[TBL] [Abstract][Full Text] [Related]
38. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
[TBL] [Abstract][Full Text] [Related]
39. H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
Mor M; Bordi F; Silva C; Rivara S; Crivori P; Plazzi PV; Ballabeni V; Caretta A; Barocelli E; Impicciatore M; Carrupt PA; Testa B
J Med Chem; 1997 Aug; 40(16):2571-8. PubMed ID: 9258364
[TBL] [Abstract][Full Text] [Related]
40. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
Wallace RM; Young JM
Mol Pharmacol; 1983 Jan; 23(1):60-6. PubMed ID: 6135145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]